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Gap junctional intercellular communication
Lipid raftLipid rafts are speciﬁc microdomains of plasma membrane which are enriched in cholesterol and sphingoli-
pids. These domains seem to favour the interactions of particular proteins and the regulation of signalling
pathways in the cells. Recent data have shown that among the proteins, which are preferentially localized
in lipid rafts, are connexins that are the structural proteins of gap junctions. Since gap junctional intercellular
communication is involved in various cellular processes and pathologies such as cancer, we were interested
to review the various observations concerning this speciﬁc localization of connexins in lipid rafts and its con-
sequences on gap junctional intercellular communication capacity. In particular, we will focus our discussion
on the role of the lipid raft–connexin connection in cancer progression. This article is part of a Special Issue
entitled: The Communicating junctions, composition, structure and characteristics.he Communicating junctions,
: +33 5 49 45 40 14.
. Defamie),
l rights reserved.© 2011 Elsevier B.V. All rights reserved.Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1866
1.1. Lipidic composition of the plasma membrane . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1866
1.2. Connexins and gap junctions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1867
2. Involvement of lipid rafts in the regulation of gap junctional intercellular communication . . . . . . . . . . . . . . . . . . . . . . . . . 1867
2.1. Evidence for connexin localization in lipid rafts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1867
2.2. Regulation of gap junctional intercellular communication by the lipid rafts. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1868
2.3. Connexins, lipid rafts and cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1868
3. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1869
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18691. Introduction
1.1. Lipidic composition of the plasma membrane
Historically, the plasma membrane has been described for long as a
ﬂuid lipid bilayer, exhibiting a uniform lipid distribution in which are
inserted moving proteins. However, more recently, it appeared that the
lipid bilayer is organized as a much more complex structure, exhibiting
a large variety of lipids, composed of hydrocarbon tails which are vari-
able in length and saturation, that are associated or not with proteins.
Such an organization is achieved throughnon-covalent bonds and allows
the establishment of several different physical states (or phases) becauseof thermodynamic considerations [1]. Therefore, according to its compo-
sition, the lipid bilayer can be structured in threemajor phases (solid-gel
phase, ﬂuid-liquid-crystalline phase, and liquid-ordered phase, Fig. 1).
The solid-gel phase (Lβ) is a consequence of immobile and tightly packed
membrane phospholipids that containmainly long saturated acyl chains.
Under physiological conditions, when membrane phospholipids are
enriched with polyunsaturated fatty acids, the membrane is as a ﬂuid-
liquid crystalline (or liquid-disordered) phase (Lα). Such a structure ex-
hibits acyl chains that have a disordered liquid organization and are char-
acterized by high lateralmobility. Finally, an intermediate liquid-ordered
phase (Lo) was also observed in mixtures containing phospholipids
enriched with saturated fatty acid (sphingolipids) associated with cho-
lesterol [2]. Lo microdomains are also called lipid rafts, ﬂoating in the
Lα phase like rafts on the ocean. Initially, these microdomains, or lipid
rafts, have been highlighted due to their low density and insolubility in
the presence of non-ionic detergents at low temperature [3]. Now, it ap-
pears that the speciﬁc interactions between lipids and membrane pro-
teins in lipid rafts allow the creation of dynamic platforms which
Fig. 1. The three major phases of lipid bilayer organization in biological membranes.
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processes [4]. The presence of proteins inserted in lipid rafts is the
consequence of speciﬁc protein interactions or post-translational
modiﬁcations (palmitoylation, myristoylation or glycosyl phospha-
tidyl inositol moieties known as “GPI anchors”) that target them to
these microdomains of the plasma membrane [5]. In addition, lipid
rafts containing these clusters of proteins are highly dynamic permitting
inclusion or exclusion of proteins and allow protection against enzymes
(like phosphatases) that could decrease their activity.
The lipid rafts actively participate in signal transduction, local cyto-
skeletal remodeling events and targeted trafﬁc of associated proteins
[6–8]. The functional role of lipid rafts was ﬁrst observed in caveolae
that are specialized invaginated membrane structures enriched in cho-
lesterol and sphingolipids and involved in endocytosis [9]. These partic-
ular lipid rafts are characterized by the presence of a small cholesterol
binding protein, caveolin, which constitutes a family of membrane pro-
teins including three members. These members are caveolin 1 (Cav-1,
an ubiquitous caveolin), caveolin 2 (in most cases, coexpressed with
caveolin 1) and caveolin 3 (replacing caveolin 1 in striatedmuscles) [10].
1.2. Connexins and gap junctions
The gap junctional intercellular communication (GJIC) is mediated
by the superfamily of connexins (Cxs), that is encoded by about twen-
ty different genes in humans [11]. Such a fundamental intercellular
communication is mediated by gap junctions that are intercellular
plasma membrane channels allowing direct intercytoplasmic ex-
change of ions and small molecules (PMb1000 Da) between adjacent
cells [12]. GJIC and their structural proteins, the connexins, have been
involved in the regulation of various biological aspects such as cell ho-
meostasis, proliferation and differentiation. These gap junctions play
an important role in tissue function but also in progression of diseases
such as cancer [13]. GJIC is tightly regulated by mechanisms including
changes in connexin expression, regulation of connexin trafﬁcking, the
assembly and the degradation of the intercellular channel and their
functional status [14–16]. Several reports suggested that Cxs involvedin GJIC could be localized in lipid raft microdomains. Moreover, it was
also shown that the assembly of gap junction and its activity could be
regulated by the lipid composition of the membrane [17–19].
In this review, we will summarize the various observations con-
cerning the localization of connexins in lipid rafts and its conse-
quences on GJIC regulation. Finally, we will discuss the role of the
lipid raft–connexin connection in cancer progression.
2. Involvement of lipid rafts in the regulation of gap junctional
intercellular communication
2.1. Evidence for connexin localization in lipid rafts
In lipid rafts, the localization ofmembrane proteins and their partners
can be observed by ﬂuorescence imaging approach [20–22]. Biochemical
techniques, like co-immunoprecipitation or co-immunolabelling, are
also used to study the tight interactions of proteins with speciﬁc
markers of the lipid rafts such as caveolins. One limitation of the use
of lipid raft protein markers is that they may be speciﬁc for particular
types of lipid rafts such as Cav-1which is amarker for caveolae. In addi-
tion, since lipid rafts are tightly packed with cholesterol and sphingoli-
pids, non-ionic detergents are generally not sufﬁcient for solubilizing
the anchored proteins. Nevertheless, the lipid rafts can be isolated
according to their light density by using sucrose gradient [23]. Follow-
ing ultracentrifugation, the lipid rafts are enriched at the lower concen-
trations or light fraction of the gradient contrary to the non-raft proteins
that are in the heavy fraction. Finally, another way to study the biolog-
ical importance of lipid rafts is to prevent their formation by depleting
cholesterol from the plasma membrane by using methyl-β-
cyclodextrin (MβC) [24,25].
Different techniques permitted to localize connexins in lipid rafts and
in particular in those containing caveolin-1 (caveolae). From such ap-
proaches, it appeared that someof themare able to interact or co-localize
speciﬁcallywith Cav-1 (Cx43, Cx32, Cx46 and Cx36)while others cannot
(Cx26 and Cx50) [26]. Cav-1 interacts with the carboxyl tail of Cx43 be-
tween residues 244 and 256 [27]. However, interactions may depend on
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interacting with Cav-1 in fetal rat lung epithelial cells [28]. Moreover,
connexins can be present in lipid rafts but without being assembled as
junctional plaques as it was observed for Cx26 and Cx32 by using differ-
ent types of detergents [29]. Indeed, all detergents do not have the same
selectivity for the speciﬁc extraction of lipid rafts and thismay give an in-
complete picture of their composition [30,31]. Despite these possible
variations of extraction, it is admitted that the ubiquitous Cx43 co-local-
izes and interacts with Cav-1 in various cell types [26,28,32].
In addition, more recent studies have demonstrated the speciﬁc lo-
calization of phosphorylated forms of connexins in lipid raft microdo-
mains. For example in lens, Cx50 and Cx46 were found to be
phosphorylated in lipid rafts containing Cav-1 [33]. And in various cell
types, phosphorylated Cx43 isoforms were preferably detected in lipid
rafts containing Cav-1 [27,28,34,35]. For instance, in these studies [33,
34], activation of PKCγ by various stimuli (H2O2 or TPA and IGF-1) stim-
ulated the interaction of this enzymewith Cav-1 and Cx43 in lipid rafts.
Once phosphorylated by PKCγ Cx43 is redistributed within the lipid
rafts leading to the disassembly of gap junction plaques and, in turn,
in decreased gap junction activity. This was the case for Cx50 and
Cx46 that could be phosphorylated by PKCγ in lipid rafts after activation
byH2O2 [33]. Similarly, in lens epithelial cells, activation of PKCγ, by TPA
or IGF-1, stimulated the interaction of PKCγ with Cav-1 and Cx43 in
lipid rafts forcing them to redistribute within that microdomain [34].
In addition, c-src, which is known to be localized in lipid rafts, can asso-
ciate with and phosphorylates Cx43 in lipid rafts containing Cav-3 [36].
In lipid rafts, Cx43 may also interact with other types of proteins
that may change its localization. For instance, if Cx43 is frequently
interacting with Cav-1 in lipid rafts [26,27,34], its interaction with
ZO-1 (Zonula occludens protein-1) allows its redistribution to the
junctional plaques in osteoblastic cells [37].
The question that arises is if and how GJIC is regulated by the lo-
calization of connexins in lipid rafts.
2.2. Regulation of gap junctional intercellular communication by the lipid
rafts
As described in the Introduction, cholesterol is an essential constitu-
ent of cell membranes that is preferentially localized in lipid rafts. This
sterol is recognized to be very important in cell membrane function,
probably due to his key function in lipid rafts [38]. The ﬁrst studies dem-
onstrating a close link between gap junctions and cholesterol in the plas-
ma membrane are electron microscopy studies after freeze fracture
made with Filipin, a cholesterol probe. By using such an approach in val-
vular endothelial cells or atrial ﬁbers, the probe uniformly labelled the
non-junctional membrane whereas, in junction areas, no sterol probe
complexeswere found [39,40]. In junctions, the absence of available cho-
lesterol for binding with Filipin might be due to sequestration of choles-
terol by connexon, a gap junction assembly. In the 1990s, other authors
have shown, by using Novikoff hepatoma cells, that gap junction assem-
bly and permeability increased after exogenous cholesterol supplemen-
tation [41]. The same team also demonstrated that gap junction
assembly could be modulated by treatments with low density lipopro-
tein (LDL) [42]. Furthermore, oxidized cholesterol (especially 7-ketocho-
lesterol) induces increased GJIC, via Cx43, in bovine lens epithelial cells,
probably by increasing the assembly and stability of Cx43 in gap junction
plaques [43]. The addition of cholesterol acts on the ﬂuidity of the lipid
bilayer and one study has shown that heptanol decreases GJIC probably
by decreasing the ﬂuidity of cholesterol-rich domains in cardiac cells
[44]. In summary, these studies suggest that cholesterol may regulate
the gap junction function. And thus, these data also suggest that GJIC
is upregulated in lipid rafts which are cholesterol-rich membrane
microdomains.
But cholesterol is not the only membrane lipid known to regulate
GJIC. Sphingolipids, aswe have seen previously, like cholesterol, are im-
portant components of the lipid bilayer, that are involved in the stabilityand formation of lipid rafts. Regarding the function of the connexons, it
has been reported that ceramides, sphingolipid metabolites that are
produced after hydrolysis by sphyngomyelinase, are inhibitors of GJIC.
It has even been said that chronic release of certain ceramides may act
as tumor promoters [45]. Another example is free fatty acids that are de-
rived from hydrolysis of membrane phospholipids, such as arachidonic
acid and its metabolites. These compounds have been shown to inhibit
GJIC of neonatal cardiac cells [46]. Thus, the lipid metabolites can also
affect the open state of connexons and their roles as GJIC modulators
have been widely observed. However, the molecular mechanisms of
these speciﬁc modulating agents remain poorly characterized.
Some studies are conﬂicting regarding the direct relationship be-
tween localization of connexins in lipid rafts and the GJIC capacity.
Two groups have shown a direct correlation between Cx43 in lipid
rafts and decreased GJIC. This was observed when the interaction be-
tween ZO-1 and Cx43 is disrupted [35]. In porcine cumulus-oocyte
complexes, the GJIC breakdown is gonadotropin-dependent and medi-
ated by clustering Cx43 in lipid rafts [47]. Conversely, some studies
reported a correlation between Cx43 localization in lipid rafts and
GJIC. For example, in lens epithelial cells, the activation of PKCγ (by
TPA or IGF-1) stimulates the interaction of this protein with Cav-1 and
Cx43 in lipid rafts, leading to a redistribution of Cx43 from the light frac-
tion to the heavy fraction. This resulted in a decrease of GJIC [34]. Like-
wise, H2O2 stimulates the phosphorylation of Cx43 in lipid rafts by
PKCγ, leading to a decrease in GJIC [48]. In enterocytes, interferon-γ
prevents the migration of these cells by inhibiting GJIC once Cx43 has
been moved out from lipid rafts [49]. In keratinocytes, the presence of
phosphorylated forms of Cx43 in lipid rafts contributes to GJIC arguing
for the Cx43/Cav-1 association as a regulator of GJIC [27].
2.3. Connexins, lipid rafts and cancer
The incidence of some solid tumors has been associated to diets rich
in saturated fat and cholesterol. And the link between lipid rafts, high
cholesterol concentration and solid tumors, particularly prostate can-
cer, has been established for long [50]. Such association between cancer
and cholesterol suggests that the lipid micro-environment could be di-
rectly involved in the process of tumorigenesis. Previous studies have
shown that lipid rafts are localized in leading fronts of migrating cells
[51,52].
Regarding the connexins, their involvement in cancer seems to be
different, even contradictory, depending on the stage of carcinogene-
sis. Indeed, connexins may act, in one hand, as tumor suppressors in
the early stages of tumor development, or, in the other hand, as pos-
sible inducers of migration and invasion of cancer cells at late stages
[13]. So far, very few studies have observed any relationship between
connexins, cancer and lipid rafts. An initial study was based on kera-
tinocytes in which Cx43 was decreased by shRNA. Treatment of
these cells with TGFβ1/TPA or TGFβ1/EGF mimicked the epithelial–
mesanchymal transition (EMT) and increased their invasion capacity.
According to the authors, Cx43 acts as a tumor suppressor by a mech-
anism that does not involve GJIC but the carboxyl-terminal part of
Cx43. It was hypothesized that the association between Cx43 and
Cav-1 is essential for preventing EMT since such interaction disap-
pears during the process [53]. In our laboratory, we also tried to un-
derstand what is the role of lipid rafts in association with Cx43 in
tumorigenesis, and more speciﬁcally during the invasive process. To
do so, we used the human U251 glioblastoma cells expressing low
levels of Cx43. By decreasing Cx43, via sh-RNA strategy, we observed
that the cell invasion capacity was dependent on the high amount of
Cx43 and its localization in lipid rafts. Such an invasive process that
was studied in organotypic brain slices was also partly dependent of
heterocellular GJIC between U251 cells and normal cells [54].
Podosomes or invadopodia are protrusions that are similar to active
proteolytic domains, localized on the ventral side of invasive tumor
cells [55]. These speciﬁc regions are enriched in integrins, soluble and
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intracellular side, signalingmachinery tyrosine kinase, actin and its asso-
ciated proteins [56–59]. Studies have shown that invadopodias exhibit
properties that are very similar tomembrane lipid rafts. Their biogenesis
and integrity also depend on the cholesterol level, ﬁnely regulated, at the
plasma membrane. Recently, it was observed that ZO-1 is a component
of invadopodia [60]. This speciﬁc localization of ZO-1 was also observed
for Cx43 in smooth muscle cells suggesting that ZO-1 and its binding
partner, Cx43, may play a novel role in invadopodia formation and, in
turn, in the regulation of cell adhesion and matrix degradation.
3. Conclusion
Lipid rafts constitute a platform enriched of signalingmolecules asso-
ciated with speciﬁc membrane proteins, found in the plasmamembrane
of cells. These microdomains can actively participate in the regulation of
connexin function. In tumor progression, connexins are known to be in-
volved in cell migration/invasion but this function may depend on their
localization in lipid rafts such as caveolae. Invadopodias are lipid raft
structures involved in matrix degradation during cell invasion and met-
astatic processes in which connexins may play a fundamental role.
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